Zydus receives FDA final approval for Diroximel fumarate delayed-release capsules, 231 mg
Diroximel fumarate delayed-release capsules, 231 mg, are indicated for the treatment of relapsing forms of multiple sclerosis
Diroximel fumarate delayed-release capsules, 231 mg, are indicated for the treatment of relapsing forms of multiple sclerosis
Dexlansoprazole delayed-release capsules are a proton pump inhibitor
Fenebrutinib targets cells in the immune system known as B cells and microglia
Relmada expects to initiate its Phase 3 program in the first half of 2026
Syngene International has reported total income of Rs. 926 crore during the period ended September 30, 2025
Sumatriptan injection is indicated in adults for the acute treatment of migraine
The approved ANDA is therapeutically equivalent to the reference listed drug (RLD), Sprycel Tablets
This latest commitment brings the British pharmaceutical company’s total investment at the site to $886 million
Oral semaglutide 25 mg was associated with the same weight loss efficacy in women with obesity regardless of menopausal stage, and patients reported improvements in physical function, respectively
Cupid has been allocated approximately 23.4 million units of female condoms per year
Subscribe To Our Newsletter & Stay Updated